One News
Breaking · 2 sources

Just broke · 2 sources · 36m ago

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

Eli Lilly's Foundayo is also approved to help treat Type 2 diabetes.

Coverage spectrum

Read at your length

Eli Lilly's Foundayo is also approved to help treat Type 2 diabetes.

Eli Lilly's Foundayo is also approved to help treat Type 2 diabetes. TORONTO - Health Canada has authorized a new GLP-1 medication for weight loss that is a pill taken every day, rather than weekly injections.

Global News Canada reported the story as "Health Canada approves new Eli Lilly GLP-1 pill for weight loss."

2 sources have covered this story, including Global News Canada and Winnipeg Free Press Sports. The earliest reporting in the cluster landed 35 minutes ago.

How each side is reporting it

Left0 outlets

How the left is reporting it

No coverage from this side yet.

Right0 outlets

How the right is reporting it

No coverage from this side yet.

How it spread

Winnipeg Free Press Sports reported it first, Nov 18, 2:48 PM ET. 2 outlets carried it over 1h 24m, all in the center.All in Canada.

Left 0Center 2Right 0No left or right outlets yet.

Time since the first report

  1. FirstWinnipeg Free Press SportsNov 18, 2:48 PM ETCenter
  2. +1h 24mGlobal News CanadaNov 18, 4:12 PM ETCenter

Claim ledger

  1. [01]
    Verified

    Core event reported by 2 independent outlets across the spectrum.

    2 corroborating · 1 primary-source link

  2. [02]
    Disputed

    Key facts present in mainstream desks; corroboration thin from wires.

    2 corroborating

Framings — how each side is covering it

All sources covering this story